NCT07109726
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07109726
Title A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Terremoto Biosciences Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists - Lake Nona RECRUITING Orlando Florida 32827 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02144 United States Details
Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Carolina BioOncology Institute RECRUITING Huntersville North Carolina 28078 United States Details
UH Cleveland Medical Center RECRUITING Cleveland Ohio 44106 United States Details
Sarah Cannon Nashville RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology RECRUITING Austin Texas 78229 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
START Center for Cancer Research RECRUITING San Antonio Texas 78229 United States Details
START Center for Cancer Research RECRUITING West Valley City Utah 84119 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
PanOncology Trials RECRUITING San Juan 00935 Puerto Rico Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field